The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 12, Issue 5, Pages 321-337
Publisher
Springer Nature
Online
2011-10-05
DOI
10.2165/11587890-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
- (2011) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
- (2011) Erica D. Dommasch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis
- (2010) Alexa Boer Kimball et al. AMERICAN JOURNAL OF MEDICINE
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
- (2010) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
- (2010) K Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
- (2010) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
- (2010) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
- (2010) Akihiko ASAHINA et al. JOURNAL OF DERMATOLOGY
- Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
- (2009) G R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality
- (2009) Srjdan Prodanovich et al. ARCHIVES OF DERMATOLOGY
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
- (2009) N. N. Mehta et al. EUROPEAN HEART JOURNAL
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
- Long-term data in the treatment of psoriasis
- (2008) D. Thaçi BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search